Krystal Biotech Inc (KRYS)
164.75
+3.92
(+2.44%)
USD |
NASDAQ |
Dec 20, 16:00
165.06
+0.31
(+0.19%)
After-Hours: 20:00
Krystal Biotech Profit Margin (Quarterly): 32.42% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Bioventus Inc | -3.47% |
| ADMA Biologics Inc | 29.96% |
| Alnylam Pharmaceuticals Inc | -22.27% |
| Amicus Therapeutics Inc | -4.75% |
| Insmed Inc | -236.0% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 6.45% |
| Return on Assets | 6.00% |
| Return on Invested Capital | 6.45% |
| Gross Profit Margin (Quarterly) | 92.03% |
| Operating Margin (Quarterly) | 41.67% |
| Return on Net Operating Assets | 22.05% |